GlassScriptPhysician profile
Lawrence M Kutz
NPI 1992825343
$3,316.86
in general payments reported to CMS, 2019-2025
21 companies · $635 in 2025
The $635 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $164 · 2021: $345 · 2022: $409 · 2023: $620 · 2024: $378 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,417 · Travel and Lodging: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.72 |
| Travel and Lodging | $215.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $900.65 | 2020-2025 | Proclaim, Prodigy, Octrode |
| Medtronic, INC. | $574.64 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Nalu Medical, INC. | $268.27 | 2023-2024 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $188.50 | 2025 | Evoke |
| Nevro Corp. | $150.00 | 2019 | |
| Corelink, LLC | $147.90 | 2023 | |
| Collegium Pharmaceutical, INC. | $140.04 | 2019-2022 | |
| Relievant Medsystems, INC. | $136.20 | 2019 | |
| Medtronic USA, INC. | $125.68 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $124.94 | 2025 | |
| Biodelivery Sciences International, INC. | $118.56 | 2019-2021 | |
| Mdd US Operations, LLC | $109.64 | 2019 | |
| Depuy Synthes Sales INC. | $76.35 | 2019 | |
| Redhill Biopharma INC. | $72.24 | 2020-2021 | |
| Daiichi Sankyo INC. | $54.76 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $27.24 | 2019 | |
| Livanova USA, INC. | $25.85 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.04 | 2025 | Relistor |
| Ge Healthcare | $20.51 | 2020 | |
| Allergan, INC. | $18.15 | 2019 | |
| Ucb, INC. | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Kutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.